ISPOR - Budget Impact Analysis (Bia) Of Cabazitaxel Introduction In Treatment Of Metastatic Hormone-Refractory Prostate Cancer (Mhrpc) In Russian Federation

Full Text

Budget Impact Analysis (Bia) Of Cabazitaxel Introduction In Treatment Of Metastatic Hormone-Refractory Prostate Cancer (Mhrpc) In Russian Federation

Abstract

Authors

R. Yagudina A. Kulikov L. Kogon

Back to Volume 16, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now